Related references
Note: Only part of the references are listed.Epigenome-Wide Analysis of DNA Methylation in Parkinson's Disease Cortex
Oliver Kaut et al.
LIFE-BASEL (2022)
Genome-wide DNA methylation differences in nucleus accumbens of smokers vs. nonsmokers
Christina A. Markunas et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis
Maren Stolp Andersen et al.
ANNALS OF NEUROLOGY (2021)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
Ruth Chia et al.
NATURE GENETICS (2021)
A meta-analysis of epigenome-wide association studies in Alzheimer's disease highlights novel differentially methylated loci across cortex
Rebecca G. Smith et al.
NATURE COMMUNICATIONS (2021)
Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders
Marta F. Nabais et al.
GENOME BIOLOGY (2021)
Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson's disease
Costanza L. Vallerga et al.
NATURE COMMUNICATIONS (2020)
Epigenomic analysis of Parkinson's disease neurons identifies Tet2 loss as neuroprotective
Lee L. Marshall et al.
NATURE NEUROSCIENCE (2020)
Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer's disease
Lanyu Zhang et al.
NATURE COMMUNICATIONS (2020)
Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex
Gemma L. Shireby et al.
BRAIN (2020)
Transcriptomic signatures of brain regional vulnerability to Parkinson's disease
Arlin Keo et al.
COMMUNICATIONS BIOLOGY (2020)
Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer's disease
Adam R. Smith et al.
CLINICAL EPIGENETICS (2019)
Advances in epigenetics link genetics to the environment and disease
Giacomo Cavalli et al.
NATURE (2019)
EpiSmokEr: a robust classifier to determine smoking status from DNA methylation data
Sailalitha Bollepalli et al.
EPIGENOMICS (2019)
Brain cell type-specific enhancer-promoter interactome maps and disease-risk association
Alexi Nott et al.
SCIENCE (2019)
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
Mike A. Nalls et al.
LANCET NEUROLOGY (2019)
How to perform a meta-analysis with R: a practical tutorial
Sara Balduzzi et al.
EVIDENCE-BASED MENTAL HEALTH (2019)
OSCA: a tool for omic-data-based complex trait analysis
Futao Zhang et al.
GENOME BIOLOGY (2019)
Genome-wide brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease
Juan Young et al.
NEUROLOGY-GENETICS (2019)
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability
Regina H. Reynolds et al.
NPJ PARKINSONS DISEASE (2019)
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study
Rita Guerreiro et al.
LANCET NEUROLOGY (2018)
Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood
Ting Qi et al.
NATURE COMMUNICATIONS (2018)
A Novel Class of ER Membrane Proteins Regulates ER-Associated Endosome Fission
Melissa J. Hoyer et al.
CELL (2018)
A unique role for DNA (hydroxy) methylation in epigenetic regulation of human inhibitory neurons
Alexey Kozlenkov et al.
SCIENCE ADVANCES (2018)
Brains for Dementia Research: Evolution in a Longitudinal Brain Donation Cohort to Maximize Current and Future Value
Paul T. Francis et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
The Emerging Evidence of the Parkinson Pandemic
E. Ray Dorsey et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Evaluation of Post-Mortem Effects on Global Brain DNA Methylation and Hydroxymethylation
Louise K. Sjoholm et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome
Bernard Ng et al.
NATURE NEUROSCIENCE (2017)
NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases
Cornelis Blauwendraat et al.
NEUROBIOLOGY OF AGING (2017)
An environment-dependent transcriptional network specifies human microglia identity
David Gosselin et al.
SCIENCE (2017)
Parkinson's disease is associated with DNA methylation levels in human blood and saliva
Yu-Hsuan Chuang et al.
GENOME MEDICINE (2017)
Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution
Maarten van Iterson et al.
GENOME BIOLOGY (2017)
CpGFilter: model-based CpG probe filtering with replicates for epigenome-wide association studies
Jun Chen et al.
BIOINFORMATICS (2016)
Epigenetic Mechanisms of Longevity and Aging
Payel Sen et al.
CELL (2016)
Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data
Kin Y. Mok et al.
LANCET NEUROLOGY (2016)
A reference panel of 64,976 haplotypes for genotype imputation
Shane McCarthy et al.
NATURE GENETICS (2016)
Next-generation genotype imputation service and methods
Sayantan Das et al.
NATURE GENETICS (2016)
Synaptic dysfunction and septin protein family members in neurodegenerative diseases
Mikael Marttinen et al.
MOLECULAR NEURODEGENERATION (2015)
Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949)
G. Davies et al.
MOLECULAR PSYCHIATRY (2015)
L-Dopa Increases α-Synuclein DNA Methylation in Parkinson's Disease Patients In Vivo and In Vitro
Ina Schmitt et al.
MOVEMENT DISORDERS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
Parkinson's Disease Correlates With Promoter Methylation in the α-Synuclein Gene
Lasse Pihlstrom et al.
MOVEMENT DISORDERS (2015)
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
Martin J. Aryee et al.
BIOINFORMATICS (2014)
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease
Katie Lunnon et al.
NATURE NEUROSCIENCE (2014)
Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci
Philip L. De Jager et al.
NATURE NEUROSCIENCE (2014)
Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms
Brigit E. Riley et al.
PLOS ONE (2014)
A data-driven approach to preprocessing Illumina 450K methylation array data
Ruth Pidsley et al.
BMC GENOMICS (2013)
A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression
Jerry Guintivano et al.
EPIGENETICS (2013)
Distinctive patterns of DNA methylation associated with Parkinson disease Identification of concordant epigenetic changes in brain and peripheral blood leukocytes
Eliezer Masliah et al.
EPIGENETICS (2013)
Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray
Yi-an Chen et al.
EPIGENETICS (2013)
From promises to practical strategies in epigenetic epidemiology
Jonathan Mill et al.
NATURE REVIEWS GENETICS (2013)
Association Between Early-Onset Parkinson Disease and 22q11.2 Deletion Syndrome Identification of a Novel Genetic Form of Parkinson Disease and Its Clinical Implications
Nancy J. Butcher et al.
JAMA NEUROLOGY (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1
Oliver Kaut et al.
NEUROGENETICS (2012)
The Impact of a Novel Apolipoprotein E and Amyloid-beta Protein Precursor-Interacting Protein on the Production of Amyloid-beta
Paul C. R. Hopkins et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease
Isidre Ferrer et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' Brains
Ahmad Jowaed et al.
JOURNAL OF NEUROSCIENCE (2010)
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria (vol 8, pg 1150, 2009)
D. W. Dickson et al.
LANCET NEUROLOGY (2010)
CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease
Lumine Matsumoto et al.
PLOS ONE (2010)
Neuropothological assessment of Parkinson's disease: refining the diagnostic criteria. (vol 8, pg 1150, 2009)
D. W. Dickson et al.
LANCET NEUROLOGY (2010)
Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium
Irina Alafuzoff et al.
ACTA NEUROPATHOLOGICA (2009)
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
Dennis W. Dickson et al.
LANCET NEUROLOGY (2009)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
The 22q11 deletion syndromes
PJ Scambler
HUMAN MOLECULAR GENETICS (2000)